Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -233 | -281 | 285 | -79 | -164 |
| Other Working Capital | -270 | -553 | 511 | -333 | -1,178 |
| Other Operating Activity | -1,855 | -2,435 | -3,563 | -2,941 | -3,824 |
| Operating Cash Flow | $-2,358 | $-3,270 | $-2,767 | $-3,353 | $-5,166 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -52 | -155 | -9 | -15 | -198 |
| Other Investing Activity | 5 | 8 | 2 | 9 | 24 |
| Investing Cash Flow | $-47 | $-147 | $-8 | $-6 | $-174 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 1,000 | N/A | N/A |
| Common Stock Issued | 2,388 | 4,794 | 1,556 | 24 | N/A |
| Other Financing Activity | -55 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $2,333 | $4,794 | $2,556 | $24 | $N/A |
| Exchange Rate Effect | 11 | -109 | -40 | 130 | -140 |
| Beginning Cash Position | 1,869 | 600 | 858 | 4,064 | 9,544 |
| End Cash Position | 1,808 | 1,869 | 600 | 858 | 4,064 |
| Net Cash Flow | $-72 | $1,377 | $-218 | $-3,335 | $-5,340 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,358 | -3,270 | -2,767 | -3,353 | -5,166 |
| Capital Expenditure | -52 | -155 | -9 | -15 | -206 |
| Free Cash Flow | -2,410 | -3,425 | -2,776 | -3,368 | -5,372 |